1. Therapeutic Drug Monitoring in the Treatment of Tuberculosis

   • Charles A. Peloquin

   Current Opinion 10 October 2012 Pages: 2169 - 2183

   

2. HMG- CoA Reductase Inhibitors as Immunomodulators

   • Liza J. Raggatt
   • Nicola C. Partridge

   Leading Article 10 October 2012 Pages: 2185 - 2191

   

3. Pharmacological Strategies to Decrease Transfusion Requirements in Patients Undergoing Surgery

   • Robert J. Porte
   • Frank W. G. Leebeek

   Therapy in Practice 10 October 2012 Pages: 2193 - 2211

   

4. Prevention of Perinatal HIV Transmission

   • Athena P. Kourtis

   Review Article 10 October 2012 Pages: 2213 - 2220

   

5. Biapenem

   • Caroline M. Perry
   • Tim Ibbotson

   Adis New Drug Profile 10 October 2012 Pages: 2221 - 2234

   

6. Biapenem

   • Yukimichi Kawada

   Adis New Drug Profile 10 October 2012 Pages: 2235 - 2235

7. Biapenem

   • Erik Nord

   Adis New Drug Profile 10 October 2012 Pages: 2235 - 2235

8. Gefitinib

   • Christine R. Culy
   • Diana Faulds

   Adis New Drug Profile 10 October 2012 Pages: 2237 - 2248

   

9. Gefitinib

   • Giuseppe Giaccone

   Adis New Drug Profile 10 October 2012 Pages: 2249 - 2249

10. Gefitinib

    • Lesley Seymour

    Adis New Drug Profile 10 October 2012 Pages: 2249 - 2249

11. Gefitinib

    • Fortunate Ciardiello

    Adis New Drug Profile 10 October 2012 Pages: 2249 - 2250

12. Extended- Release Methylphenidate (Ritalin® LA)

    • Katherine A. Lyseng-Williamson
    • Gillian M. Keating

    Adis New Formulation Profile 10 October 2012 Pages: 2251 - 2259

    

13. Extended-Release Methylphenidate (Ritalin® LA)

    • Daniel J. Safer

    Adis New Drug Profile 10 October 2012 Pages: 2260 - 2260

14. Extended-Release Methylphenidate (Ritalin® LA)

    • Sharon B. Wigal

    Adis New Drug Profile 10 October 2012 Pages: 2260 - 2261

15. Budesonide (Entocort® EC Capsules)

    • Kate McKeage
    • Karen L. Goa

    Adis Drug Evaluation 10 October 2012 Pages: 2263 - 2282

    

16. Danaparoid

    • Tim Ibbotson
    • Caroline M. Perry

    Adis Drug Evaluation 10 October 2012 Pages: 2283 - 2314